Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors.
Curtis KK, Sarantopoulos J, Northfelt DW, Weiss GJ, Barnhart KM, Whisnant JK, Leuschner C, Alila H, Borad MJ, Ramanathan RK. Curtis KK, et al. Among authors: whisnant jk. Cancer Chemother Pharmacol. 2014 May;73(5):931-41. doi: 10.1007/s00280-014-2424-x. Epub 2014 Mar 8. Cancer Chemother Pharmacol. 2014. PMID: 24610297 Free PMC article. Clinical Trial.
A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or recurrent ovarian cancer.
Chelariu-Raicu A, Nick A, Urban R, Gordinier M, Leuschner C, Bavisotto L, Molin GZD, Whisnant JK, Coleman RL. Chelariu-Raicu A, et al. Among authors: whisnant jk. Gynecol Oncol. 2021 Feb;160(2):418-426. doi: 10.1016/j.ygyno.2020.11.013. Epub 2020 Nov 23. Gynecol Oncol. 2021. PMID: 33243443 Clinical Trial.
CpG oligodeoxynucleotide enhances tumor response to radiation.
Milas L, Mason KA, Ariga H, Hunter N, Neal R, Valdecanas D, Krieg AM, Whisnant JK. Milas L, et al. Among authors: whisnant jk. Cancer Res. 2004 Aug 1;64(15):5074-7. doi: 10.1158/0008-5472.CAN-04-0926. Cancer Res. 2004. PMID: 15289307
Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis.
Leventhal BG, Kashima HK, Weck PW, Mounts P, Whisnant JK, Clark KL, Cohen S, Dedo HH, Donovan DJ, Fearon BW, et al. Leventhal BG, et al. Among authors: whisnant jk. Arch Otolaryngol Head Neck Surg. 1988 Oct;114(10):1163-9. doi: 10.1001/archotol.1988.01860220097032. Arch Otolaryngol Head Neck Surg. 1988. PMID: 3046638 Clinical Trial.
38 results